NuScale’s Q2 results triggered a modestly negative market reaction (-0.2%), reflecting mixed investor sentiment on commercial progress and ongoing execution risks rather than clear positive or negative surprises.
Shares fell 7.2% after NuScale disappointed investors by failing to provide updated guidance and not addressing near-term revenue visibility, leaving concerns over deceleration and cautious outlook unanswered.